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The Complete Health Improvement Program (CHIP) and Reduction of Chronic Disease 
Risk Factors in the Philippines 
 
L M Kent*1, D P Morton1, J T Mañez2 S Q Mañez2, G D Yabres2 A B Muya2, P M Rankin1 H A 
Diehl3 
1Lifestyle Research Centre, Avondale College of Higher Education, 582 Freemans Drive, Cooranbong, NSW 
2265, Australia 
2Health & Wellness Department, Adventist Medical Centre, 1975 Corner Donada and San Juan Street, Pasay 
City, Manila 1300, Philippines 
3Lifestyle Medicine Institute,  25805 Barton Rd, Bldg. A, Ste. 106, Loma Linda, California, USA 92354 
 
ABSTRACT 
 
Lifestyle modification has been demonstrated to effectively reduce the risk factors associated with chronic disease. 
The Complete Health Improvement Project, a 30-day diet and lifestyle modification program, has been shown to be 
efficacious in the US, Australasia and Canada. The present study examined the changes in selected biometric 
measures of 61 participants from six programs delivered in Manila, in the Philippines (May 2013 to November 
2014). Overall, significant reductions were recorded in body mass (2.2%, p<0.001), systolic and diastolic blood 
pressure (6.0%, p<0.001 and 3.3%, p=0.040; respectively), total cholesterol (9.1%, p<0.001), low-density 
lipoprotein cholesterol (6.8%, p=0.021), and fasting blood sugar (12.4%, p=0.001). Overall, triglyceride levels did 
not change significantly over the course of the intervention (p=0.299). Stratification of the data revealed more 
dramatic responses in those presenting with the greatest risk factor levels. Those presenting with cholesterol levels 
>5.17mmol/l recorded an average reduction of 14.4%. A mean decrease of 17.0% in low-density lipoprotein levels 
was observed among those who entered the program with a low-density lipoprotein level >3.35 mmol/l. Individuals 
who presented with triglycerides >2.26 mmol/l recorded a mean reduction of 21.8%. Individuals with systolic blood 
pressure above 139 mmHg and diastolic blood pressure above 89 mmHg decreased levels by 10.3% and 7.1%, 
respectively. Finally, fasting plasma glucose decreased on average 24.8% among individuals entering the program 
with levels above 6.9 mmol/l. In conclusion, significant reductions in chronic disease risk factors can be achieved in 
a 30-day life style intervention delivered in the Philippines. 
 
Keywords: Chronic disease, risk factors, Philippines, lifestyle intervention, nutrition. 
Introduction
The burden of chronic diseases, including 
cardiovascular disease, diabetes and cancer, represents 
a major health challenge worldwide [1,2]. Deaths from 
chronic diseases are projected to increase by 15% by 
2020 worldwide [1]. In the Philippines, the probability 
of dying from one the four main chronic diseases in 
2014—cardiovascular disease (CVD), cancer, 
respiratory disease and diabetes—is one of the highest 
in the world, at 27.9%[1].  
_______________________________ 
*Correspondence  
Dr. L M Kent 
Lifestyle Research Centre, Avondale College of Higher 
Education, 582 Freemans Drive, Cooranbong, NSW 
2265, Australia. 
 
Unhealthy lifestyle is recognized as one of the major 
risk factors of chronic diseases[1] and lifestyle 
interventions have been shown to be efficacious for 
their primary, secondary and early tertiary prevention 
[3-7].Consequently, lifestyle interventions are 
attracting increasing attention for managing the 
burgeoning rise of chronic disease. The Complete 
Health Improvement Program (CHIP) is an intensive, 
community-based lifestyle intervention that focuses on 
the promotion of a whole-food, plant-based eating 
pattern, and also encourages daily moderate-intensity 
physical activity. The program is managed and 
coordinated by the not-for-profit Lifestyle Medicine 
Institute; it has been used in clinical settings[8], 
workplace environments[9], and community settings, 
and has been facilitated by Seventh-day Adventist 
churches[6,7]. Over the past 15 years, an estimated 
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50,000 people have completed the CHIP program 
worldwide, which has demonstrated significant 
benefits for the management of cardiovascular disease 
(CVD)[6-8,10], type 2 diabetes mellitus[6,11], and 
depression[12].While the program was developed for a 
United States audience, recent studies from Australasia 
and Canada[7,13] have shown similar levels of 
effectiveness, despite the inherent cultural differences. 
The purpose of this study was to examine the short-
term effectiveness of CHIP in reducing selected 
chronic disease risk factors in the Western Pacific 
context. 
 
Materials and Methods 
 
The study examined the changes in selected chronic 
disease risk factors of 62 individuals (age = 
51.4±13.5yrs, 41% male/59% female) who chose to 
participate in one of 6 CHIP interventions in the 
Adventist Medical Center Manila.The programs ranged 
in size from 6 to 13 participants (mean group size = 
10.3). Participants were encouraged to engage in the 
program in consultation with their personal health care 
provider.Consent for the study was obtained from 
Avondale College of Higher Education Human 
Research Ethics Committee(Approval No. 20:10:07). 
The CHIP interventions were advertised on social 
networking sites (Facebook), internet podcasts, 
newspaper articles by local journalists, information 
sessions to local businesses and churches, posters and 
billboards around the Adventist Medical Center Manila 
premises and distribution of brochures to hospital 
visitors, patients and residents of the local community. 
In some instances local medical practitioners 
recommended the program to their patients to the 
program. Of the 62 participants who enrolled in the 
program, 61 (98%) completed the 30-day intervention 
after which they were followed up via phone calls, text 
messages, social network messages and announcement 
posts and encouraged to visit the Adventist Medical 
Center Manila, Health and Wellness Department for 
monitoring of their health status through individual and 
group consultations, attendance of health forums, 
attendance of cooking classes and annual CHIP alumni 
and anniversary events. Participants were deemed to 
have completed the program if they attended all of the 
18 sessions and underwent both pre and post-
intervention blood testing. As shown in Table 1, at 
program entry the participants were representative of 
an at-risk population with a mean BMI in the 
‘overweight’ category (26.5 kg/m2), ‘diabetic’ fasting 
blood sugar (FBS) levels (7.2mmol/L), 
‘prehypertensive’ systolic and diastolic blood pressures 
(129 mmHg and 84.6 mmHg, respectively) and above 
‘optimal’ low-density lipoprotein (LDL-C) cholesterol 
levels (2.6 mmol/L).The programs were facilitated by a 
subsidised Filipino Lifestyle Medicine physician who 
had an interest in positively influencing the health of 
members of their local community. The facilitator was 
a health professional, although not all the staff involved 
in the program mechanics were. The facilitator 
underwent three days of training to develop group 
facilitation skills after which they were provided with a 
comprehensive CHIP resource package that included a 
curriculum guide for program delivery, 18 pre-recorded 
educational lectures presented by qualified experts, a 
cookbook and participant textbook and journal. The 
role of the facilitator was to organize and facilitate the 
proceedings of the group sessions, not to educate. Even 
though the facilitator had medical training, the supplied 
resources were used and the program delivery was 
consistent. The CHIP intervention involved 18 three-
hour group sessions over 30 days. Each session 
typically involved viewing a thirty to forty-five minute 
pre-recorded lecture which covered the following 
themes: the causes of chronic disease; the benefits of 
positive lifestyle choices, with particular attention to 
diet and physical activity as therapy for conditions 
including obesity, type 2 diabetes, and CVD;and 
positive psychology and how it influences long-term 
health habits, including stress management, 
forgiveness, and self-worth. The objective of the CHIP 
intervention was to educate and empower individuals 
to provide intelligent self-care. The program involved a 
conglomerate of behaviour change strategies but was 
principally founded on the theory of planned 
behaviour, which asserts that behaviour is determined 
by intentions; these, in turn, are formed by attitudes, 
social norms, and perceived behavioural control[14]. 
The program endeavoured to change participants’ 
attitudes toward positive lifestyle choices through 
education, create new social norms through a group 
setting, and increase perceived behavioural control by 
providing an intensive experience in which positive 
changes were experienced in a short time. The primary 
focus of the intervention, however, was a whole-food, 
plant-based eating pattern ad libitum. The consumption 
of whole grains, legumes, and fresh fruits and 
vegetables was recommended for the achievement of a 
daily target of fewer than 20% of calories from fat, 
fewer than 10 tsp of added sugar, less than 5000 mg of 
salt (2000 mg of sodium), and less than 50 mg of 
cholesterol. Participants were also encouraged to 
consume 2 to 3 L of water daily[10].Furthermore, daily 
exercise (30 minutes at moderate intensity or 10,000 
pedometer recorded steps) was advocated.In addition to 
the pre-recorded lecture, each session also included a 
cooking demonstration, buffet meal, group discussion 
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and a behaviour change challenge. The cooking 
demonstration usually involved food assemblage 
demonstrations in which recipes from the CHIP 
cookbook and local recipes based on CHIP dietary 
principles were presented. Shopping tours, nutrition 
workshops and guided exercise sessions were also 
incorporated into the program when local health 
experts could be sourced. Participants paid a fee of 
approximately 27,500Philippine pesos to cover the cost 
of venue hire, buffet meals atevery session, resources 
including reading materials and pedometer, and 
biomedical assessments. 
 
Biometric measurement 
 
At program entry and after 30 days, participants’ 
height, weight, blood pressure (BP), and 12-hour lipids 
and FBS were measured. Height, weight, and resting 
BP were measured at the Adventist Medical Center 
Manila, where the CHIP intervention was conducted. 
Height and weight were measured at the same time of 
day; participants removed their shoes and light clothing 
was worn on each occasion. For the sake of 
consistency, resting BP was measured by the same 
health professional at each site. The blood samples 
were collected by trained phlebotomists not involved in 
the program and were analysed at the Adventist 
Medical Center Manila’s laboratory department for 
total cholesterol (TC), LDL-C, high-density lipoprotein 
cholesterol(HDL-C), triglycerides (TG), and FBS. 
 
Statistical analysis 
 
The data were analysed with SPSS Statistics (version 
19, IBMCorp, Armonk, NY, 2010). Data are expressed 
as means ± standard deviations.Paired t-tests were used 
to assess changes in the biometric measures from 
baseline to post-intervention, both forthe overall and 
stratified data. McNemar’s chi-square testing was used 
to determine changes from program entry to 30 days in 
the distribution of participants across the various risk 
factor categories. Participants' weight was 
characterized using standard cut points but the highest 
categories were combined due to small numbers: BMI 
as normal, overweight, and obese[15]; BP was 
classified using the Fifth Joint National Committee for 
Hypertension guidelines[16]; and FBS was 
characterized according to conventional normal, 
impaired, and diabetic levels[17]. The National 
Cholesterol Education Program Adult Treatment Panel 
III classification system[17]was used to categorize the 
participants for all risk factors except total cholesterol, 
for which the Framingham risk classification[18], 
which had a greater number of categories than the 
National Cholesterol Education Program Adult 
Treatment Panel III classification system. P < .05 was 
considered significant. To reduce the Type 1 error that 
can occur when simultaneous tests are performed in a 
data set, Bonferroni correction was applied to each 
biometric separately. Because there was a different 
number of risk category comparisons for each 
biometric, the correction applied was 0.05/n, where n 
was the number of categories within each biometric. 
 
Results 
 
Participants’ mean changes from baseline to post-
intervention are presented in Table 1“INSERT TABLE 
1 HERE”. Significant reductions were recorded in all 
biometric measures, except triglycerides, with the most 
notable being in TC,LDL-C and FBS. Table 
2“INSERT TABLE 2 HERE” displays the stratified 
data, using conventional risk factor categories. 
Participants who entered with the highest risk factor 
classifications tended to have the greatest 
improvements and the effect sizes were moderate to 
large. As Table 2“INSERT TABLE 2 HERE” 
indicates, many participants who entered the program 
with the highest risk factor classifications had moved 
to lower risk factor classifications by the end of the 
intervention. Among the 15 individuals with elevated 
TC levels (>5.2mmol/L) at program entry, this 
biometric was normalised in10 (67%). Similarly, of the 
11 individuals with elevated LDL-C levels at baseline, 
6 (55%) experienced a reduction in scores to below 
3.35mmol/L in the 30 days. Further, of the 23 
individuals with elevated SBP at baseline, 11 (48%) 
reduced this to below 139 mmHg. A comparison of the 
risk factor reductions in this study with those recently 
reported in the United States [6], Australasia [7] and 
Canada[13]appears in Table 3“INSERT TABLE 3 
HERE”. Similar outcomes were observed in the four 
cohorts, except for LDL-C, FBS and TG, where 
changes were significantly lower, higher and did not 
change, respectively, compared to the other three 
cohorts. 
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Table 1: Mean changes in selected chronic diseases risk factors from baseline to post-intervention 
 
 N Baseline 
Mean 
SD Post- 
Mean 
SD Mean 
change 
Lower 
CI 
Upper 
CI 
% 
change 
t p-value Cohen’s 
d 
Total 
Cholesterol, 
mmol/l 
61 4.69 0.88 4.27 0.82 -0.43 0.26 0.59 -9.1 5.29 <0.001 0.68 
High-density 
Lipoprotein, 
mmol/l 
61 1.28 0.38 1.05 0.29 -0.23 0.15 0.30 -17.8 5.99 <0.001 0.77 
Low-density 
Lipoprotein, 
mmol/l 
61 2.70 0.80 2.51 0.70 -0.18 0.03 0.34 -6.8 2.38 0.021 0.30 
Triglyceride, 
mmol/l 
61 1.50 0.71 1.57 0.65 0.07 -0.22 0.07 5.0 -1.05 0.299 -0.17 
Fasting Blood 
Sugar, mmol/l 
61 7.16 4.37 6.28 2.75 -0.89 0.35 1.42 -12.4 3.33 0.001 0.43 
Body Mass 
Index, kg/m2 
61 26.5 7.82 25.9 7.49 -0.59 0.37 0.82 -2.2 5.31 <0.001 0.68 
Systolic Blood 
Pressure, mmHg 
61 129 18.4 121.3 13.8 -7.70 5.13 10.3 -6.0 5.98 <0.001 0.77 
Diastolic Blood 
Pressure, mmHg 
61 84.6 12.9 81.8 11.2 -2.79 0.14 5.44 -3.3 2.10 0.040 0.27 
 
Table 2: Changes in chronic disease risk factor levels within 30 days according to initial risk factor 
classification 
 
 Bas Post
- N 
Base- 
Mean 
SD SE Post- 
Mea
n 
SD SE Mean 
chang
e 
SD SE Lower 
CI 
Upp
er 
CI 
% 
chang
e 
t 
Total cholesterol, 
mmol/l 
Χ
2
=16.0*              
<4.14 17 31 3.61 0.4
0 
0.1
0 
3.49 0.5
3 
0.13 -0.11 0.4
6 
0.1
1 
-0.13 3.50 -3.10 0
.
9
9 
4.14-5.16 29 20 4.74 0.2
7 
0.0
5 
4.35 0.6
4 
0.12 -0.40 0.6
9 
0.1
3 
0.13 0.66 -8.34* 3
.
1
1 
>5.17 15 10 5.83 0.4
4 
0.1
1 
4.99 0.6
6 
0.17 -0.84 0.4
5 
0.1
2 
0.59 1.09 -
14.4*
* 
7
.
2
1 
High-density 
lipoprotein, mmol/l 
Χ
2
=20.3**              
>1.54 16 4 1.78 0.2
4 
0.0
6 
1.29 0.3
6 
0.09 -0.49 0.3
7 
0.0
9 
0.29 0.69 -
27.7*
* 
5
.
2
8 
1.03-1.54 men, 
1.30-1.54 women 
18 14 1.32 0.1
5 
0.0
4 
1.07 0.2
3 
0.05 -0.25 0.2
2 
0.0
5 
0.14 0.36 -
18.8*
* 
4
.
7
5 
<1.03 men, 1.30 
women 
27 43 0.97 0.1
9 
0.0
4 
0.91 0.1
9 
0.04 -0.06 0.1
4 
0.0
3 
0 0.11 -6.06 2
.
2
0 
Low-density 
lipoprotein, mmol/l 
Χ
2
=5.88               
<2.59 26 34 1.97 0.4
3 
0.0
8 
2.15 0.5
0 
0.10 0.19 0.4
6 
0.0
9 
-0.37 0 9.40 -
2
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.
0
7 
2.59-3.35 24 21 2.94 0.1
9 
0.0
4 
2.58 0.5
8 
0.12 -0.36 0.5
6 
0.1
1 
0.12 0.60 -12.3* 3
.
1
6 
>3.35 11 6 3.90 0.4
7 
0.1
4 
3.23 0.8
0 
0.24 -0.66 0.5
0 
0.1
5 
0.33 1.00 -17.0* 4
.
4
1 
Triglycerides, 
mmol/l 
Χ
2
=0.643               
<1.69 39 37 1.06 0.3
2 
0.0
5 
1.27 0.4
6 
0.07 0.20 0.4
5 
0.0
7 
-0.35 -
0.06 
19.5* -
2
.
9
0 
1.69-2.25 14 17 1.96 0.1
5 
0.0
4 
2.05 0.6
8 
0.18 0.10 0.7
0 
0.1
9 
-0.50 0.31 4.86 -
0
.
5
1 
>2.26 8 7 2.79 0.5
5 
0.2
0 
2.18 0.5
1 
0.18 -0.61 0.1
7 
0.0
6 
0.47 0.75 -
21.8*
* 
1
0
.
4 
Fasting Blood 
Sugar, mmol/l 
Χ
2
=5.57               
<5.50 34 39 4.83 0.3
7 
0.0
6 
4.87 0.3
7 
0.06 0.04 0.3
1 
0.0
5 
-0.15 0.07 0.85 -
0
.
7
8 
5.50-6.90 11 8 5.87 0.3
9 
0.1
2 
5.45 0.4
2 
0.13 -0.43 0.5
3 
0.1
6 
0.07 0.79 -7.28 2
.
6
8 
>6.9 15 13 13.4 4.9
0 
1.2
7 
10.1 3.2
7 
0.84 -3.33 2.9
8 
0.7
7 
1.68 4.98 -24.9* 4
.
3
4 
Body mass index, 
kg/m2 
Χ
2
=3.00              
<18.50 4 3 17.5 1.0
1 
0.5
1 
18.0 0.7
3 
0.36 0.55 1.6
7 
0.8
3 
-3.20 2.10 3.15 -
0
.
6
6 
18.50-24.99 26 29 22.1 1.9
3 
0.3
8 
21.6 1.7
4 
0.34 -0.46 0.7
5 
0.1
5 
0.16 0.76 -2.08* 3
.
1
1 
25.00-29.99 20 18 26.8 1.0
7 
0.2
4 
26.0 0.9
8 
0.22 -0.75 0.4
7 
0.1
0 
0.53 0.97 -
2.80*
* 
7
.
1
8 
>29.99 11 11 39.5 9.2
0 
2.7
7 
38.5 8.9
4 
2.69 -1.05 1.0
3 
0.3
1 
0.35 1.74 -2.65* 3
.
3
6 
Systolic blood 
pressure, mmHg 
Χ
2
=13.6*              
<120 13 18 105.4 6.6
0 
1.8
3 
107 10.
32 
2.86 1.54 5.5
5 
1.5
4 
-4.89 1.81 1.46 -
1
.
0
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Χ
2 McNemar Chi-squared Test; **p<0.001, *Bonferroni correction applied: difference in change at p< .017 with 3 
risk categories, p<0.012 with 4 risk categories 
Table3: Comparison of the mean changes in selected chronic disease risk factors from baseline to post-
intervention in the present study and CHIP participants from Australasia and the United States 
 
Biometric Australasia United States Canada Philippines 
 
(N=787) (N=5070) (N=1008) (N=61) 
BMI -3.8% -3.2% -3.1% -2.2% 
SBP -5.6% -4.9% -5.4% -6.0% 
DBP -4.6% -5.3% -5.3% -3.3% 
TC -14.7% -11.0% -11.3% -9.1% 
LDL -17.9% -13.0% -12.9% -6.8% 
HDL -8.3% -8.6% -8.8% -17.8% 
TG -12.5% -7.7% -8.2% 5.0% 
FPS -5.6% -6.1% -7.0% -12.4% 
 
 
Discussion 
 
The current study findings suggest that the CHIP 
intervention, which centers on a whole food, plant-
based eating pattern, can lead to rapid and meaningful 
reductions in chronic disease risk factors in the 
Western Pacific context. Further, individuals at greatest 
risk experience the greatest benefits. That these 
outcomes can be achieved with a subsidized, 
hospital/community-based intervention is noteworthy, 
given the burgeoning rise in chronic disease in the 
Western Pacific. Of note is the fact that in only 30 
days, improvements of approximately 15-20% were 
observed in participants with the highest classifications 
of TC (14%), LDL-C (17%), TG (22%), and FBS 
(25%). The changes in TC and LDL-C compare 
favorably with those achieved by pharmaceutical 
interventions involving statins [19], and exceed the 
typical expectations of dietary interventions for 
lowering blood lipids[20].The program’s emphasis on a 
whole-food, plant-based eating pattern, which is 
largely free from exogenous cholesterol, low in 
0 
120-139 25 32 124 5.0
0 
1.0
0 
118 7.4
6 
1.49 -5.60 7.1
2 
1.4
2 
2.66 8.54 -4.52* 3
.
9
3 
>139 23 11 148 12.
0 
2.5
1 
133 11.
8 
2.45 -15.2 9.4
7 
1.9
8 
11.1 19.3 -
10.3*
* 
7
.
7
1 
Diastolic blood 
pressure, mmHg 
Χ
2
=2.08              
<80 11 15 65.5 5.2
2 
1.5
8 
68.2 8.7
4 
2.64 2.73 6.4
7 
1.9
5 
-7.07 1.62 4.17 -
1
.
4
0 
80-89 22 20 80.0 0 0 79.6 8.4
4 
1.80 -0.45 8.4
4 
1.8
0 
-3.29 4.20 -0.57 0
.
2
5 
>89 28 26 95.7 7.9
0 
1.4
9 
88.9 7.8
6 
1.49 -6.79 11.
6 
2.1
9 
2.30 11.3 -7.09* 3
.
1
1 
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saturated fat, and high in fibre may explain the large 
changes. The substantial reduction in serum TC and 
LDL-C, leading to a decreased need for reverse 
cholesterol transport, may also explain the acute 
reduction in HDL-C seen in this study and others that 
advocated a plant-based eating pattern 
[7,21,22].Interestingly, the change in LDL-C was about 
half that reported in the US[6], Australasian[7] and 
Canadian studies[13].The mean baseline levels of 
LDL-C in the current study, which is much lower than 
in the other three cohorts, may explain the smaller 
changes following this intervention. As noted above, 
individuals at greatest risk experience the greatest 
benefits and this may also explain why the changes in 
FBS were about twice as great as those in the US, 
Australasia and Canadian studies. In the present study 
mean baseline FBS was indicative of diabetes, while in 
the other three cohorts, this ranged from 5.5-5.8 
mmol/l[6,7,13].This trend is supported by national 
prevalence data for impaired glucose tolerance and 
diabetes in the Philippines[23]and in the US[24], 
Australia and Canada[23].It is not clear why 
triglyceride levels increased following the intervention 
when in the other international sites, triglycerides 
decreased substantially, although it is noteworthy that 
many of the Filipino participants did attest to drinking 
some fruit juice to replace soda and on the occasion of 
no available unpolished rice, would take polished/white 
rice or white rice noodles instead.  
 
Lifestyle interventions and prevention 
 
Many chronic diseases have lifestyle underpinnings [1] 
and this observation has led to the growing awareness 
that lifestyle interventions have merit at all levels of 
prevention. In terms of primary prevention, results of 
the 52-country INTERHEART study[25] indicated that 
positive lifestyle practices, such as the consumption of 
fruits and vegetables, physical activity, and avoidance 
of tobacco use, can prevent up to 90% of myocardial 
infarctions. In terms of secondary prevention, the 
Diabetes Prevention Program Research Group[26] 
showed a 16-session lifestyle education program to be 
twice as effective as pharmaceuticals (metformin) for 
preventing the progression of prediabetes to diabetes in 
at-risk patients. At the tertiary level, several studies 
have included an exploration of lifestyle medicine 
interventions for potential chronic disease regression 
[4, 27, 28] and most have been centered on a whole-
food, plant-based diet high in fibre (>30 g) and lowing 
fat (<20%), cholesterol, and refined sugar. The 
Lifestyle Heart Trial[4] demonstrated CVD reversal 
through plant-based nutrition combined with exercise, 
social support, and stress management techniques, 
while Esselstyn[27]showed regression of heart disease 
when a low-fat (<10%)plant-based diet alone was used. 
Barnard et al.[28] reported that approximately40% of 
people with type 2 diabetics mellitus treated with 
insulin could discontinue its use through participation 
in a 26-day residential program involving a near-
vegetarian, low-fat diet in conjunction with exercise. In 
the current study, about 13% of participants who 
entered the program with FBS levels indicative of 
diabetes experienced reductions to levels below this 
classification in 30 days. This observation is lower than 
our findings in CHIP participants from the US and 
Australasia, however the mean FBS at this 
classification was about 30% higher in the Philippines 
than it was in either the US or Australasia [6,7]. 
 
Confounders and limitations 
 
Several confounders may explain the magnitude of the 
changes observed in the biometric risk factors 
measured in this study. Firstly, as the participants were 
self-selected, they likely entered the program with an 
elevated readiness for change and hence willingness to 
engage in the intervention [29]. Evidence for this can 
been seen in the very high program completion rate 
(98%), which was likely influenced by the participant 
shaving to pay to be involved. The generalizability of 
the findings to less motivated populations needs to be 
determined. Second, the extent to which regression to 
the mean explains the observed improvements is 
undetermined, as the study had no control group. 
Consistent with regression to the mean is that the 
individuals with the most extreme baseline measures 
tended to experience the greatest improvements and 
hence inclination towards the norm. However, given 
that the same trends were observed on other studies 
with large size [6, 7, 13] and that for some of the 
biometrics the high-risk categories moved up to 1.5 
standard deviations, regression to the mean likely is 
only a small component of the changes. Further, a 
small, randomized controlled trial of the CHIP 
intervention in the United States showed changes in the 
treatment group of similar magnitude to those observed 
in the current study [8].A further limitation is that 
medication changes were not recorded. Several 
anecdotal reports from participants in this study 
indicated that personal physicians decreased doses or 
even discontinued participants’ medications (e.g., for 
hypertension,hypercholesterolemia,or hyperglycemia) 
during the 30 days of the intervention. While this is a 
desirable outcome, reduced medication usage may have 
caused the results to be understated. Similarly, program 
compliance data were not collected, and, while the 
biometric changes suggest participants changed their 
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health behaviors, the extent to which this occurred is 
unknown. Presumably, the participants entered the 
program with different health behaviours and made 
varying degrees of change throughout the intervention. 
Further studies are in process to explore the influence 
of these factors on the outcomes achieved in the 
program. Notwithstanding the limitations in the 
research design, the current study results are 
noteworthy, given the size of the sample and the effects 
observed. 
 
Conclusions and Recommendations 
 
The results indicate that, within the Western Pacific 
context, the CHIP intervention can meaningfully 
improve chronic disease risk factors within 30 days, 
especially among at-risk individuals. The nutrition-
centered CHIP intervention, which can be delivered in 
a cost effective manner in the community setting, 
shows promise for assistance with the management of 
chronic diseases in the western Pacific. 
A randomized controlled trial is warranted to 
investigate the effectiveness and longer-term 
sustainability of the improvements in chronic disease 
risk factors. Improvements in participant’s chronic 
disease risk factors have been observed for up to 4 
years after the CHIP intervention in Australasia [30], 
but a sustainability study is needed in the Western 
Pacific. A further investigation of the acceptability of 
the specific nutritional recommendations of the CHIP 
intervention in the Western Pacific setting is also 
required. 
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